Cancer rates are rising among younger people aged under 50. Here’s what we know about the causes – and what the evidence says ...

UC San Diego study of global lung cancer shows mutations that lead to cancer are common in people who live in cities with bad air pollution. But cancer mutations are quite close to normal among ...

The FDA granted accelerated approval to the tyrosine kinase inhibitor sunvozertinib (Zegfrovy) for advanced non-small cell ...

The treatment marks the only targeted oral treatment in patients with non–small cell lung cancer with epidermal growth factor ...

Eight years after it was established partly by AstraZeneca, Dizal Pharmaceuticals has gained its first FDA approval, winning an accelerated nod for Zegfrovy (sunvozertinib) to become the only ...

Corticosteroids, a commonly prescribed medication to alleviate cancer-related symptoms for non-small cell lung cancer ...

Lung cancer is the third most common type of cancer in Wales but is by far the leading cause of cancer deaths. Sadly, most cases of lung cancer are detected at a late stage when the cancer has spread ...

A study shows for the first time the relationship between this disease and the damage caused to DNA by breathing pollution.

Australia’s new lung cancer screen program further disadvantages Aboriginal and Torres Strait Islander peoples, who are ...

NEW YORK – The US Food and Drug Administration on Wednesday granted accelerated approval to Dizal's oral EGFR inhibitor Zegfrovy (sunvozertinib) as a treatment for patients with locally advanced or ...

Researchers at McMaster University, Cleveland Clinic and Case Comprehensive Cancer Center have uncovered how a protein long ...

Screening for disease, including cancer, can cause harm —during screening, diagnosis and treatment. With lung cancer ...